Clinical Chemistry Analyzers - Medical Devices Pipeline Assessment, 2017

2017-08-01
Price :
Published : Aug-2017
No. of Pages : 215
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
2.1 Clinical Chemistry Analyzers Overview 9
3 Products under Development 10
3.1 Clinical Chemistry Analyzers - Pipeline Products by Stage of Development 10
3.2 Clinical Chemistry Analyzers - Pipeline Products by Segment 11
3.3 Clinical Chemistry Analyzers - Pipeline Products by Territory 12
3.4 Clinical Chemistry Analyzers - Pipeline Products by Regulatory Path 13
3.5 Clinical Chemistry Analyzers - Pipeline Products by Estimated Approval Date 14
3.6 Clinical Chemistry Analyzers - Ongoing Clinical Trials 15
4 Clinical Chemistry Analyzers - Pipeline Products under Development by Companies 16
4.1 Clinical Chemistry Analyzers Companies - Pipeline Products by Stage of Development 16
4.2 Clinical Chemistry Analyzers - Pipeline Products by Stage of Development 18
5 Clinical Chemistry Analyzers Companies and Product Overview 19
5.1 All Medicus Co Ltd Company Overview 19
5.1.1 All Medicus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 19
5.2 Analyticon Biotechnologies AG Company Overview 20
5.2.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 20
5.3 Ativa Medical Inc Company Overview 23
5.3.1 Ativa Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 23
5.4 Aviv Biomedical, Inc. Company Overview 24
5.4.1 Aviv Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
5.5 Beckman Coulter Inc Company Overview 25
5.5.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 25
5.6 Curetis NV Company Overview 26
5.6.1 Curetis NV Pipeline Products & Ongoing Clinical Trials Overview 26
5.7 Daxor Corp Company Overview 28
5.7.1 Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview 28
5.8 DiaSys Diagnostic Systems GmbH Company Overview 29
5.8.1 DiaSys Diagnostic Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview 29
5.9 Emergent Detection Inc (Inactive) Company Overview 31
5.9.1 Emergent Detection Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 31
5.10 Hansjorg Wyss Institute for Biologically Inspired Engineering Company Overview 32
5.10.1 Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview 32
5.11 Illumina, Inc. Company Overview 33
5.11.1 Illumina, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
5.12 Instrumentation Laboratory Company Company Overview 35
5.12.1 Instrumentation Laboratory Company Pipeline Products & Ongoing Clinical Trials Overview 35
5.13 Invivomon Inc (Inactive) Company Overview 38
5.13.1 Invivomon Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 38
5.14 I-Sens Inc Company Overview 39
5.14.1 I-Sens Inc Pipeline Products & Ongoing Clinical Trials Overview 39
5.15 MyCartis NV Company Overview 40
5.15.1 MyCartis NV Pipeline Products & Ongoing Clinical Trials Overview 40
5.16 NanoIVD Inc Company Overview 41
5.16.1 NanoIVD Inc Pipeline Products & Ongoing Clinical Trials Overview 41
5.17 National Institute of Biomedical Imaging and Bioengineering Company Overview 42
5.17.1 National Institute of Biomedical Imaging and Bioengineering Pipeline Products & Ongoing Clinical Trials Overview 42
5.18 NeuMoDx Molecular, Inc Company Overview 43
5.18.1 NeuMoDx Molecular, Inc Pipeline Products & Ongoing Clinical Trials Overview 43
5.19 OPKO Health Inc Company Overview 44
5.19.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 44
5.20 Samsung Electronics Co., Ltd. Company Overview 47
5.20.1 Samsung Electronics Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 47
5.21 Smiths Detection Group Limited Company Overview 49
5.21.1 Smiths Detection Group Limited Pipeline Products & Ongoing Clinical Trials Overview 49
5.22 The Hong Kong University of Science and Technology Company Overview 50
5.22.1 The Hong Kong University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 50
5.23 Theranos Inc Company Overview 51
5.23.1 Theranos Inc Pipeline Products & Ongoing Clinical Trials Overview 51
5.24 Thermal Gradient Inc Company Overview 52
5.24.1 Thermal Gradient Inc Pipeline Products & Ongoing Clinical Trials Overview 52
6 Clinical Chemistry Analyzers- Recent Developments 53
6.1 Jul 26, 2017: Thermo Fisher Scientific Reports Second Quarter 2017 Results 53
6.2 Jul 25, 2017: Cologuard revenue increased to $57.6 million during second quarter; Test volume grew 149 percent from second quarter of 2016 to 135,000 completed tests 54
6.3 Jul 25, 2017: ERBA Diagnostics Appoints David Barka as Interim Chief Executive Officer, Nikhil Vazirani as Member of the Board 55
6.4 Jul 20, 2017: bioMerieux - Second-Quarter 2017 Business Review 56
6.5 Jul 20, 2017: Abbott Reports Second-Quarter 2017 Results 58
6.6 Jul 11, 2017: Promega First to Achieve Third-Party Certification of Published ISO 18385 Manufacturing Standard to Minimize Risk of Human DNA Contamination in Forensic Products 60
6.7 Jul 06, 2017: Kurt H. Kruger joins Qualigen's Board of Directors 61
6.8 Jul 06, 2017: Richard David, MD, FACS joins Qualigen's Board of Directors 61
6.9 Jul 03, 2017: Premaitha Health Litigation Update 62
6.10 Jun 29, 2017: Sphere Medical confirms compatibility of Proxima bedside blood gas monitoring system with leading global monitoring company 62
6.11 Jun 29, 2017: MSP bodmann appointed as new distributor in Germany 63
6.12 Jun 14, 2017: Alere Reports First Quarter 2017 Financial Results 63
6.13 Jun 13, 2017: FlowJo and BD to Provide Cloud Platform for Real-Time Single-Cell Marketing Collaboration 64
6.14 Jun 12, 2017: New Immobilized Lux Chiral LC-SFC Selector from Phenomenex Delivers Broad Enantioselectivity 65
6.15 Jun 06, 2017: BD Releases 2016 Sustainability Report 65
6.16 Jun 05, 2017: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2016 Financial Results 66
6.17 May 31, 2017: Daxor Announces Hiring of Chief Financial Officer 66
6.18 May 24, 2017: Curetis Provides Business and Financial Update for the First Quarter 2017 67
6.19 May 22, 2017: Illumina Names Mark Van Oene Chief Commercial Officer, Sales Leader Brings Genomics Expertise and Strong Commercial Leadership Experience to the Role 69
6.20 May 22, 2017: Alere Provides Preliminary Unaudited Financial Results 69
6.21 May 16, 2017: Boule Diagnostics optimizes the manufacturing structure - shuts down the Chinese production facility 70
6.22 May 16, 2017: Akers Biosciences Announces Q1 2017 Earnings 70
6.23 May 11, 2017: Boule Diagnostics: interim report January-March 2017 72
6.24 May 09, 2017: OPKO Health Reports 2016 Financial and Operating Results 73
6.25 May 04, 2017: Siemens: Earnings Release and Financial Results Q2 FY 2017: Another strong quarter - profitable growth continuing 74
6.26 May 04, 2017: PerkinElmer Announces Financial Results for the First Quarter of 2017 76
6.27 May 04, 2017: Bio-Rad Reports First-Quarter 2017 Financial Results 77
6.28 May 02, 2017: BD Announces Results For 2017 Second Fiscal Quarter 78
6.29 May 02, 2017: QIAGEN reports results for first quarter 2017 80
6.30 May 01, 2017: Luminex Reports Record First Quarter 2017 Financial Results; Raises 2017 Financial Guidance 83
6.31 Apr 28, 2017: IDEXX Laboratories Announces First Quarter Results-2017 83
6.32 Apr 27, 2017: Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2017 and Declares Quarterly Cash Dividend 86
6.33 Apr 26, 2017: Thermo Fisher Scientific Reports First Quarter 2017 Results 87
6.34 Apr 25, 2017: Illumina Reports Financial Results for First Quarter of Fiscal Year 2017 88
6.35 Apr 23, 2017: BD Announces Appointment Of Tom Polen As President 90
6.36 Apr 20, 2017: bioMerieux - First-Quarter 2017 Business Review 90
6.37 Apr 19, 2017: Abbott Reports First-Quarter 2017 Results 93
6.38 Apr 17, 2017: Toshiba Medical Names Dan Skyba Director of Ultrasound Business Unit 95
6.39 Apr 12, 2017: Curetis Reports Full-Year 2016 Financial Results and Updates 2017 Guidance 96
6.40 Apr 12, 2017: Curetis Expands Supervisory and Medical Advisory Boards 97
6.41 Apr 11, 2017: Akers Bioscience: Financial Results for the Year Ended December 31, 2016 98
6.42 Apr 11, 2017: Akers Biosciences Reports Earnings for Fiscal Year 2016 99
6.43 Apr 06, 2017: Curetis Starts Subsidiary Ares Genetics to Advance Genetic Antibiotic Resistance Testing 103
6.44 Apr 03, 2017: Supervisory Board of Siemens Healthineers ensures management continuity 105
6.45 Apr 01, 2017: New Release of H30 Fully Automated Hematology Analyzer 105
6.46 Mar 31, 2017: HORIBA Instruments commences operations at new factory in Houston 105
6.47 Mar 30, 2017: Akers Biosciences Reports Preliminary Unaudited Earnings Highlights for Fiscal Year 2016 106
6.48 Mar 28, 2017: BD Announces Success of Helping Build Healthy Communities Program, Launches New Effort Focused on Medication Therapy Management 108
6.49 Mar 27, 2017: Boule Diagnostics increases focus on Indonesia - Receives grant from Swedfund 108
6.50 Mar 23, 2017: PerkinElmer to Display Portfolio of Cancer Research Technologies and Workflow Solutions at 2017 AACR Annual Meeting 109
6.51 Mar 21, 2017: Retractable Technologies Announces Litigation Updates 110
6.52 Mar 20, 2017: EKF Diagnostics Holdings: Final results 111
6.53 Mar 17, 2017: Eva Schulz-Kamm appointed global head of Government Affairs at Siemens 111
6.54 Mar 14, 2017: Hospital ICU study demonstrates significant reduction in time to blood gas result using Sphere Medical's Proxima 111
6.55 Mar 13, 2017: Bio-Rad Intends to Propose Three New Independent Directors 112
6.56 Mar 13, 2017: Bio-Rad Initiates Long Term Financial Guidance; Commits to Defining Long Term Capital Allocation Targets and Hosting an Annual Investor Day 113
6.57 Mar 09, 2017: Alere Provides Update on Arriva Medical 114
6.58 Mar 07, 2017: Beckman Coulter Diagnostics Receives FDA Clearance for its DxC 700 AU Chemistry Analyzer 115
6.59 Mar 03, 2017: OPKO Health Appoints Dr. Akhtar Ashfaq as Renal Division Senior Vice President, Clinical Research and Development 115
6.60 Mar 01, 2017: OPKO Health Reports 2016 Financial and Operating Results 116
6.61 Mar 01, 2017: Thermo Fisher Scientific Elects New Director to Board 117
6.62 Feb 23, 2017: VBio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results 118
6.63 Feb 23, 2017: Bio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results 120
6.64 Feb 23, 2017: Renishaw exhibiting at BioWales 2017 122
6.65 Feb 20, 2017: Illumina Names John W. Thompson to Its Board of Directors, Bringing More Than 40 Years of Technology Leadership to Illumina 122
6.66 Feb 07, 2017: Sphere Medical showcasing next generation Proxima bedside blood gas analyser at German critical care congresses 123
6.67 Feb 06, 2017: Luminex Reports Fourth Quarter And Full Year 2016 Results 123
6.68 Feb 02, 2017: PerkinElmer Announces Financial Results for Fourth Quarter and Full Year 2016 124
6.69 Feb 02, 2017: BD Announces Results For 2017 First Fiscal Quarter 126
6.70 Feb 01, 2017: Jim Hagemann Snabe proposed as new Chairman of Siemens' Supervisory Board 127
6.71 Feb 01, 2017: QIAGEN Reports Results for Fourth Quarter and Full-year 2016 128
6.72 Jan 31, 2017: Curetis' Global Installed Base Expanding to Over 150 Unyvero Analyzers 132
6.73 Jan 31, 2017: Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2016 Results 133
6.74 Jan 31, 2017: Siemens: First Quarter Results FY 2017 135
6.75 Jan 31, 2017: Illumina Reports Full Financial Results for Fourth Quarter and Fiscal Year 2016 135
6.76 Jan 27, 2017: Illumina Names Caroline Dorsa to Its Board of Directors, Adding Over 30 Years of Leadership Experience in the Healthcare, Telecommunications and Energy Industries 137
6.77 Jan 26, 2017: Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2017, Declares Quarterly Cash Dividend 138
6.78 Jan 23, 2017: ISO 17025 Accreditation for Microbiology Manufacturing Site Offers Increased Confidence to Microbiology Testing Laboratories 139
6.79 Jan 19, 2017: bioMerieux - Fourth-Quarter 2016 Business Review 140
6.80 Jan 13, 2017: Eppendorf: William Linton is new member of the Supervisory Board 142
6.81 Jan 10, 2017: Abaxis Reports Preliminary Financial Performance For The Third Quarter Of Fiscal 2017 142
6.82 Jan 10, 2017: New CEO and Group President at Boule Diagnostics 143
6.83 Jan 09, 2017: Luminex Announces Preliminary Revenue for Fourth Quarter 2016 and Issues 2017 Revenue Guidance 143
6.84 Jan 06, 2017: Theranos Announces Company Re-engineers Operations 144
6.85 Jan 04, 2017: Roche launches cobas c 513 analyzer and HbA1c Gen. 3 assay to meet increasing demand for testing of people with diabetes 144
6.86 Jan 04, 2017: Alere Laboratory Receives ABFT Accreditation 145
6.87 Jan 04, 2017: Alere Provides Update on Arriva Medical 145
6.88 Jan 03, 2017: Illumina Taps Garret Hampton, One of the World's Leading Clinical Genomics Experts, to Head its Clinical Genomics Unit 145
6.89 Dec 28, 2016: Alere Provides Update on Arriva Medical 146
6.90 Dec 20, 2016: Illumina Names Jonathan Seaton as Senior Vice President for Corporate & Business Development, Adding Further Clinical and Life Sciences Expertise to its Executive Team 147
6.91 Dec 19, 2016: Instrumentation Laboratory Receives US FDA Clearance For New GEM Premier 5000 Critical Care Testing System 147
6.92 Dec 19, 2016: OPKO Health to be Added to the NASDAQ Biotechnology Index 148
6.93 Dec 14, 2016: Beckman Coulter appoints IT Product Manager for Northern Europe 148
6.94 Dec 08, 2016: Khang & Khang Announces Securities Class Action Lawsuit against Alere and Reminds Investors with Losses to Contact the Firm 149
6.95 Dec 07, 2016: Illumina appoints senior vice president and CFO 149
6.96 Dec 07, 2016: Abbott Seeks To Terminate Alere Acquisition 150
6.97 Dec 07, 2016: Illumina Extends Management Team, Appoints Sam A. Samad as Senior Vice President and Chief Financial Officer 150
6.98 Nov 29, 2016: ERBA Diagnostics names interim CEO 150
6.99 Nov 21, 2016: Agenix: Retirement of Director 151
6.100 Nov 21, 2016: Agenix: Change of Registered Office 151
6.101 Nov 18, 2016: Curetis Publishes Business and Financial Update for the First Nine Months 2016 152
6.102 Nov 18, 2016: Renishaw appoints a new distributor in the Nordic region 153
6.103 Nov 14, 2016: Akers Biosciences Announces Q3 Earnings 154
6.104 Nov 10, 2016: Diasorin Group Reports Continued Growth In Revenues And Profitability In The Third Quarter 2016 155
6.105 Nov 09, 2016: Boule Diagnostics interim report January-September 2016 156
6.106 Nov 08, 2016: Exact Sciences Appoints Jeff Elliott Chief Financial Officer 157
6.107 Nov 07, 2016: OPKO Health Reports Third Quarter Financial and Operating Results 158
6.108 Nov 07, 2016: PerkinElmer Announces Financial Results for the Third Quarter of 2016 159
6.109 Nov 07, 2016: Pierre Boulud appointed Corporate Vice Presidentof the Asia Pacific region at bioMerieux 160
6.110 Nov 04, 2016: Alere Reports Third Quarter 2016 Financial Results 161
6.111 Nov 03, 2016: BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance 161
6.112 Nov 02, 2016: QIAGEN Reports Results for Third Quarter and First Nine Months of 2016 163
6.113 Nov 02, 2016: Lak Ananth to head new next47 startup unit 166
6.114 Nov 02, 2016: QIAGEN launches restructuring initiatives, revises outlook for 2016 earnings and provides initial net sales and adjusted earnings guidance for 2017 167
6.115 Nov 01, 2016: Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of 9.1 Percent 167
6.116 Nov 01, 2016: Illumina Reports Full Financial Results for Third Quarter of Fiscal Year 2016 168
6.117 Nov 01, 2016: Asuragen Launches QuantideX NGS RNA Lung Cancer Kit 169
6.118 Nov 01, 2016: Introducing Renishaw's new RA802 Pharmaceutical Analyser 170
6.119 Oct 31, 2016: Luminex Reports Third Quarter 2016 Results; Raises Full Year Guidance 171
6.120 Oct 31, 2016: Changes in the Management Board of Eppendorf 171
6.121 Oct 27, 2016: Thermo Fisher Scientific Reports Third Quarter 2016 Results 171
6.122 Oct 25, 2016: Abaxis Reports Financial Performance For The Second Quarter Of Fiscal 2017 173
6.123 Oct 20, 2016: bioMerieux-Business Review for the nine months ended September 30, 2016 175
6.124 Oct 20, 2016: QIAGEN launches QIAscout for single-cell isolation 178
6.125 Oct 20, 2016: Kyowa Medex to exhibit at MEDICA 2016, Messe Dusseldorf, Germany, Nov 14-17 2016 179
6.126 Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results 179
6.127 Oct 18, 2016: Agenix: US sales and key appointment 182
6.128 Oct 17, 2016: PerkinElmer Elects Samuel Chapin to Board of Directors 182
6.129 Oct 17, 2016: Thermo Fisher Scientific Enables Preemptive Pharmacogenomic Screening Research with New PharmacoScan Solution 182
6.130 Oct 17, 2016: New design of hematology and clinical chemistry analyzers 183
6.131 Oct 14, 2016: Agenix: Appointment of Independent Non- Executive Directors 184
6.132 Oct 10, 2016: Illumina Announces Preliminary Revenue for Third Quarter of Fiscal Year 2016 184
6.133 Sep 26, 2016: PerkinElmer Announces New Organizational Structure 184
6.134 Sep 24, 2016: Proxima Demonstrated at NVIC Congress Following Significant Sale in Benelux 185
6.135 Sep 23, 2016: Siegfried Russwurm to resign by mutual agreement from the Siemens Management Board 185
6.136 Sep 15, 2016: Unique in-line blood gas analyser selected to feature in BACCN annual conference Simulation Lab 186
6.137 Sep 13, 2016: OPKO Health Appoints Jane Pine Wood as Chief Legal and Compliance Officer of BioReference Laboratories 186
6.138 Sep 12, 2016: Patient-dedicated blood gas analysis enhances flu readiness and infection control 187
6.139 Sep 12, 2016: EKF Diagnostics Holdings: Half-year Report 187
6.140 Sep 06, 2016: Alere Reports Second Quarter 2016 Financial Results 190
6.141 Aug 31, 2016: bioMerieux - First-Half 2016 Results 191
6.142 Aug 30, 2016: Sphere Medical expands sales into Belgium 195
6.143 Aug 30, 2016: AGENIX Announces Annual Result For The Year Ended 30 June 2016 195
6.144 Aug 19, 2016: Curetis Reports Financial Results for the First Six Months of 2016 196
6.145 Aug 17, 2016: Alere Reports First Quarter 2016 Financial Results 198
6.146 Aug 11, 2016: Akers Biosciences Announces H1 and Q2 2016 Earnings 199
6.147 Aug 08, 2016: OPKO Health Reports Improved Financial and Operating Results 201
6.148 Aug 08, 2016: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2015 Financial Results 202
6.149 Aug 04, 2016: BD Announces Results For 2016 Third Fiscal Quarter 204
6.150 Aug 04, 2016: PerkinElmer Announces Financial Results for the Second Quarter of 2016 206
6.151 Aug 04, 2016: Diasorin Group Revenues And EBITDA Reached Record highs In the Second Quarter 2016 207
6.152 Aug 03, 2016: Bio-Rad Reports Second-Quarter 2016 Financial Results 211
6.153 Aug 03, 2016: Kyowa Medex Announced Insurance Coverage of "25-Hydroxyvitamin D Assay" 211
7 Appendix 212
7.1 Methodology 212
7.2 About GlobalData 215
7.3 Contact Us 215
7.4 Disclaimer 215

1.1 List of Tables
Table 1: Clinical Chemistry Analyzers - Pipeline Products by Stage of Development 10
Table 2: Clinical Chemistry Analyzers - Pipeline Products by Segment 11
Table 3: Clinical Chemistry Analyzers - Pipeline Products by Territory 12
Table 4: Clinical Chemistry Analyzers - Pipeline Products by Regulatory Path 13
Table 5: Clinical Chemistry Analyzers - Pipeline Products by Estimated Approval Date 14
Table 6: Clinical Chemistry Analyzers - Ongoing Clinical Trials 15
Table 7: Clinical Chemistry Analyzers Companies - Pipeline Products by Stage of Development 16
Table 8: Clinical Chemistry Analyzers - Pipeline Products by Stage of Development 18
Table 9: All Medicus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 19
Table 10: Biosensor System - AST/ALT - Product Status 19
Table 11: Biosensor System - AST/ALT - Product Description 19
Table 12: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 20
Table 13: Biolyzer 100 - Product Status 20
Table 14: Biolyzer 100 - Product Description 20
Table 15: Biolyzer 300 - Product Status 21
Table 16: Biolyzer 300 - Product Description 21
Table 17: Biolyzer 600 - Product Status 21
Table 18: Biolyzer 600 - Product Description 22
Table 19: Ativa Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 23
Table 20: Ativa Micro-Lab System - Product Status 23
Table 21: Ativa Micro-Lab System - Product Description 23
Table 22: Aviv Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
Table 23: Bili-4 Hematofluorometer - Product Status 24
Table 24: Bili-4 Hematofluorometer - Product Description 24
Table 25: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 25
Table 26: DxC 700 AU - Product Status 25
Table 27: DxC 700 AU - Product Description 25
Table 28: Curetis NV Pipeline Products & Ongoing Clinical Trials Overview 26
Table 29: Unyvero Analyzer - Product Status 26
Table 30: Unyvero Analyzer - Product Description 27
Table 31: Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview 28
Table 32: Total Blood Volume Analyzer - Total Body Albumin - Product Status 28
Table 33: Total Blood Volume Analyzer - Total Body Albumin - Product Description 28
Table 34: DiaSys Diagnostic Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview 29
Table 35: QDx Lipidcheck - Product Status 29
Table 36: QDx Lipidcheck - Product Description 29
Table 37: respons940 - Product Status 30
Table 38: respons940 - Product Description 30
Table 39: Emergent Detection Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 31
Table 40: BodyKey Fat Loss Sensor - Product Status 31
Table 41: BodyKey Fat Loss Sensor - Product Description 31
Table 42: Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview 32
Table 43: Paper-Based Microfluidic Analytical System - Product Status 32
Table 44: Paper-Based Microfluidic Analytical System - Product Description 32
Table 45: Illumina, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
Table 46: LSD-100 Lysosomal Storage Enzyme Analyzer - Product Status 33
Table 47: LSD-100 Lysosomal Storage Enzyme Analyzer - Product Description 34
Table 48: Instrumentation Laboratory Company Pipeline Products & Ongoing Clinical Trials Overview 35
Table 49: GEM Premier 5000 - Glucose/Lactate/Total Bilirubin - Product Status 35
Table 50: GEM Premier 5000 - Glucose/Lactate/Total Bilirubin - Product Description 35
Table 51: GEM Premier 5000 - Hemoglobin And Oxygen Saturation - Product Status 36
Table 52: GEM Premier 5000 - Hemoglobin And Oxygen Saturation - Product Description 36
Table 53: GEM Premier 5000 - pH/pCO2/pO2 - Product Status 36
Table 54: GEM Premier 5000 - pH/pCO2/pO2 - Product Description 37
Table 55: GEM Premier 5000 System - Product Status 37
Table 56: GEM Premier 5000 System - Product Description 37
Table 57: Invivomon Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 38
Table 58: Miniature Analyzer - Product Status 38
Table 59: Miniature Analyzer - Product Description 38
Table 60: I-Sens Inc Pipeline Products & Ongoing Clinical Trials Overview 39
Table 61: Blood Gas Analyzer - Product Status 39
Table 62: Blood Gas Analyzer - Product Description 39
Table 63: MyCartis NV Pipeline Products & Ongoing Clinical Trials Overview 40
Table 64: Evalution - Product Status 40
Table 65: Evalution - Product Description 40
Table 66: NanoIVD Inc Pipeline Products & Ongoing Clinical Trials Overview 41
Table 67: NanoIVD Clinical Analyzer-I - Product Status 41
Table 68: NanoIVD Clinical Analyzer-I - Product Description 41
Table 69: National Institute of Biomedical Imaging and Bioengineering Pipeline Products & Ongoing Clinical Trials Overview 42
Table 70: Microfluidic Diagnostic Card - Product Status 42
Table 71: Microfluidic Diagnostic Card - Product Description 42
Table 72: NeuMoDx Molecular, Inc Pipeline Products & Ongoing Clinical Trials Overview 43
Table 73: NeuMoDx 500 Molecular IVD System - Product Status 43
Table 74: NeuMoDx 500 Molecular IVD System - Product Description 43
Table 75: OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 44
Table 76: Claros 1 Analyzer - Product Status 44
Table 77: Claros 1 Analyzer - Product Description 44
Table 78: OPKO Health Inc - Ongoing Clinical Trials Overview 45
Table 79: Claros 1 Analyzer - Claros 1 Clinical Trial for Total PSA 46
Table 80: Samsung Electronics Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 47
Table 81: LABGEO PT10 - Product Status 47
Table 82: LABGEO PT10 - Product Description 48
Table 83: Smiths Detection Group Limited Pipeline Products & Ongoing Clinical Trials Overview 49
Table 84: Bio-Seeq - Clinical - Product Status 49
Table 85: Bio-Seeq - Clinical - Product Description 49
Table 86: The Hong Kong University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 50
Table 87: Portable Real-time PCR System - Product Status 50
Table 88: Portable Real-time PCR System - Product Description 50
Table 89: Theranos Inc Pipeline Products & Ongoing Clinical Trials Overview 51
Table 90: miniLab System - Product Status 51
Table 91: miniLab System - Product Description 51
Table 92: Thermal Gradient Inc Pipeline Products & Ongoing Clinical Trials Overview 52
Table 93: Flash HT - Product Status 52
Table 94: Flash HT - Product Description 52
Table 95: Glossary 214

1.2 List of Figures
Figure 1: Clinical Chemistry Analyzers - Pipeline Products by Stage of Development 10
Figure 2: Clinical Chemistry Analyzers - Pipeline Products by Segment 11
Figure 3: Clinical Chemistry Analyzers - Pipeline Products by Territory 12
Figure 4: Clinical Chemistry Analyzers - Pipeline Products by Regulatory Path 13
Figure 5: Clinical Chemistry Analyzers - Pipeline Products by Estimated Approval Date 14
Figure 6: Clinical Chemistry Analyzers - Ongoing Clinical Trials 15
Filed in: Medical Device
Publisher : GlobalData